World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
37519
World Ranking
9587
National Ranking
529

Overview

Lars E. French is affiliated with Ludwig-Maximilians-Universität München in Germany and has contributed extensively to the field of medicine, with a focus on dermatology. Their publication record spans various dermatological topics with an emphasis on skin diseases and related conditions.

Their research covers several subfields including:

  • Dermatology
  • Oncology
  • Epidemiology
  • Immunology
  • Pathology and Forensic Medicine

The main topics addressed in their work include:

  • Cutaneous Melanoma Detection and Management
  • Drug-Induced Adverse Reactions
  • Autoimmune Bullous Skin Diseases
  • Cutaneous lymphoproliferative disorders research
  • Urticaria and Related Conditions
  • Cancer Immunotherapy and Biomarkers
  • Dermatology and Skin Diseases

Recent noteworthy papers by Lars E. French include:

  • Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases (2021), published in Journal of the American Academy of Dermatology
  • The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries (2020), published in Journal of the American Academy of Dermatology
  • Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries (2020), published in Journal of the American Academy of Dermatology
  • Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts (2021), published in European Journal of Cancer
  • Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study (2021), published in Journal of the American Academy of Dermatology

Lars E. French has frequently collaborated with several coauthors within their research network, including:

  • Markus Reinholz
  • Daniela Hartmann
  • Elke Sattler
  • Benjamin M. Clanner-Engelshofen
  • Carola Berking

Their work has been published in leading dermatology and oncology journals. The most frequent publication venues include:

  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of Investigative Dermatology
  • Journal of the American Academy of Dermatology
  • European Journal of Cancer

Best Publications

  • Inhibition of death receptor signals by cellular FLIP

    Martin Irmler;Margot Thome;Michael Hahne;Pascal Schneider

  • Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

    M. Hahne;D. Rimoldi;M. Schröter;P. Romero

  • Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

    Isabelle Viard;Philippe Wehrli;Roberto Bullani;Pascal Schneider

  • MyD88, an adapter protein involved in interleukin-1 signaling.

    Kimberly Burns;Fabio Martinon;Christoph Esslinger;Heike Pahl

  • APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

    Michael Hahne;Takao Kataoka;Michael Schröter;Kay Hofmann

  • Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

    Devon E. McMahon;Erin Amerson;Misha Rosenbach;Jules B. Lipoff

  • Toxic epidermal necrolysis and Stevens-Johnson syndrome

    Thomas Harr;Lars E French

  • Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.

    L E French;M Hahne;I Viard;G Radlgruber

  • Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

    P Saas;P R Walker;M Hahne;A L Quiquerez

  • Activation of the IL-1β-Processing Inflammasome Is Involved in Contact Hypersensitivity

    Hideki Watanabe;Olivier Gaide;Virginie Pétrilli;Fabio Martinon

  • The TRAIL to selective tumor death

    Lars E. French;Jürg Tschopp

  • TRAMP, a Novel Apoptosis-Mediating Receptor with Sequence Homology to Tumor Necrosis Factor Receptor 1 and Fas(Apo-1/CD95)

    Jean-Luc Bodmer;Kim Burns;Pascal Schneider;Kay Hofmann

  • Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins: Multicenter Retrospective Analysis of 48 Consecutive Cases

    Christa Prins;Francisco A. Kerdel;R. Steven Padilla;Thomas Hunziker

  • The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.

    Esther E. Freeman;Devon E. McMahon;Jules B. Lipoff;Misha Rosenbach

  • Diagnostic delay in hidradenitis suppurativa is a global problem.

    D.M. Saunte;J. Boer;A. Stratigos;J.C. Szepietowski

  • T cell costimulation by the TNF ligand BAFF.

    Bertrand Huard;Pascal Schneider;Davide Mauri;Jürg Tschopp

  • FAS Engagement Induces the Maturation of Dendritic Cells (Dcs), the Release of Interleukin (Il)-1β, and the Production of Interferon γ in the Absence of IL-12 during Dc–T Cell Cognate Interaction: A New Role for FAS Ligand in Inflammatory Responses

    Maria Rescigno;Vincent Piguet;Barbara Valzasina;Suzanne Lens

  • Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.

    Lars E French

  • Diagnosis and management of nail pigmentations

    Ralph Peter Braun;Robert Baran;Frederique Anne Le Gal;Stephane Dalle

  • Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment.

    Afsaneh Alavi;Lars E. French;Mark D. Davis;Alain Brassard

Frequent Co-Authors

Reinhard Dummer
Reinhard Dummer University of Zurich
Jean-Hilaire Saurat
Jean-Hilaire Saurat University of Geneva
Jürg Tschopp
Jürg Tschopp University of Lausanne
Carola Berking
Carola Berking Ludwig-Maximilians-Universität München
Matthias Augustin
Matthias Augustin Universität Hamburg
Dragana Jankovic
Dragana Jankovic National Institute of Allergy and Infectious Diseases
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich
Georg Stingl
Georg Stingl Medical University of Vienna
Pascal Schneider
Pascal Schneider University of Lausanne
Michael Hahne
Michael Hahne Centre national de la recherche scientifique, CNRS

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA doesn’t always mean following a traditional path. Many students and working professionals are now exploring flexible online degree options to enter or advance in healthcare careers. Whether you’re starting your journey or looking to specialize, online programs provide valuable opportunities to learn at your own pace and balance other commitments.

For those interested in nursing, online adn programs for non nurses make it possible for newcomers to step into the healthcare field quickly. If you’re already a registered nurse, affordable rn to bsn programs offer a streamlined way to earn a bachelor’s degree and enhance your qualifications.

Graduates in other fields can consider online msn programs for non nurses, which are designed for those seeking fast-track entry into advanced nursing roles. For nurses aiming to reach the highest professional level, online nursing phd programs provide a pathway to leadership, research, and teaching positions.

Exploring these related online degrees can open doors to diverse and rewarding healthcare careers beyond traditional medical school.

Best Scientists Citing Lars E. French

Trending Scientists